Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl II):ii14–7.
Article PubMed PubMed Central Google Scholar
Coates LC, Anderson RR, Fitzgerald O, et al. Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol. 2008;35(7):1438–42.
Lubrano E, Scriffignano S, Perrotta FM. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol. 2019;46(11):1428–30.
Coates LC, Soriano ER, Corp N, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465–79. https://doi.org/10.1038/s41584-022-00798-0.
Article PubMed PubMed Central Google Scholar
Lubrano E, Scriffignano S, de Vlam K, Ronga M, Perrotta FM, Lories R. Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise—a review. RMD Open. 2023;9(3):e003339. https://doi.org/10.1136/rmdopen-2023-003339.
Article PubMed PubMed Central Google Scholar
Perrotta FM, Scriffignano S, Benfaremo D, Ronga M, Luchetti MM, Lubrano E. New insights in physical therapy and rehabilitation in psoriatic arthritis: a review. Rheumatol Ther. 2021;8(2):639–49.
Article PubMed PubMed Central Google Scholar
Lubrano E, Scriffignano S, Perrotta FM. Difficult to treat and refractory to treatment in psoriatic arthritis. Rheumatol Ther. 2023;10(5):1119–25.
Article PubMed PubMed Central Google Scholar
Bixio R, Bonetto C, Fracassi E, et al. Depression as a possible determinant of fatigue in patients with axial spondyloarthritis. Clin Exp Rheumatol. 2024;42(5):1015–9.
Husni ME, Merola JF, Davin S. The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum. 2017;47(3):351–60. https://doi.org/10.1016/j.semarthrit.2017.05.010.
Jankowiak B, Kowalewska B, Krajewska-Kułak E, Khvorik DF, Niczyporuk W. Relationship between self-esteem and stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2020;37(4):597–602. https://doi.org/10.5114/ada.2020.93242.
Article PubMed PubMed Central Google Scholar
Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Cañete JD, Perrotta FM. Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study. Rheumatol Ther. 2020;7(4):825–36. https://doi.org/10.1007/s40744-020-00229-0.
Article PubMed PubMed Central Google Scholar
Bąk-Sosnowska M, Gruszczyńska M, Wyszomirska J, Daniel-Sielańczyk A. The influence of selected psychological factors on medication adherence in patients with chronic diseases. Healthcare (Basel). 2022;10(3):426. https://doi.org/10.3390/healthcare10030426.
Currado D, Saracino F, Ruscitti P, et al. Pain catastrophizing negatively impacts drug retention rate in patients with psoriatic arthritis and axial spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study. Arthritis Res Ther. 2024;26(1):162.
Article CAS PubMed PubMed Central Google Scholar
Perrotta FM, Musto A, Lubrano E. New insights in physical therapy and rehabilitation in axial spondyloarthritis: a review. Rheumatol Ther. 2019;6(4):479–86.
Article PubMed PubMed Central Google Scholar
Bartholomew E, Chung M, Yeroushalmi S, Hakimi M, Bhutani T, Liao W. Mindfulness and meditation for psoriasis: a systematic review. Dermatol Ther (Heidelb). 2022;12(10):2273–83. https://doi.org/10.1007/s13555-022-00802-1.
Jadon DR, Helliwell PS. The role of the multidisciplinary team in the management of psoriatic arthritis. Musculoskelet Care. 2022;20(Suppl 1):S32–40. https://doi.org/10.1002/msc.1690.
Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31(11):1409–17. https://doi.org/10.1007/s00296-011-1999-3.
Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39(1):217–25. https://doi.org/10.1007/s10067-019-04734-8.
Harvima RJ, Viinamäki H, Harvima IT, et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol. 1996;76(6):467–71.
Article CAS PubMed Google Scholar
Chaudhary R, Prasad A, Agarwal V, et al. Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. Int Immunopharmacol. 2023;125(Pt A): 111046.
Article CAS PubMed Google Scholar
Evers AW, Verhoeven EW, Kraaimaat FW, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol. 2010;163:986–91. https://doi.org/10.1111/j.1365-2133.2010.09984.x.
Article CAS PubMed Google Scholar
Richards HL, Ray DW, Kirby B, et al. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol. 2005;153(6):1114–20. https://doi.org/10.1111/j.1365-2133.2005.06817.x.
Article CAS PubMed Google Scholar
Hall JM, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME. Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract. 2012. https://doi.org/10.1155/2012/403908.
Article PubMed PubMed Central Google Scholar
Hailey LH, Amarnani R, Bundy C, et al. Lifestyle modifications and nonpharmacologic interventions to improve outcomes in psoriatic arthritis: a systematic review. Clin Ther. 2023;45(9):841–51.
Højgaard P, Glintborg B, Hetland ML, et al. Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registry. Ann Rheum Dis. 2015;74(12):2130–6. https://doi.org/10.1136/annrheumdis-2014-205389.
Article CAS PubMed Google Scholar
Freire M, Rodríguez J, Möller I, et al. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics. Reumatol Clin. 2011;1:20–6.
Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76(11):1906–10.
Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2022;74(9):1430–4.
Zhao SS, Jones GT, Hughes DM, et al. Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis. Rheumatology. 2021;60(12):5734–42.
Article CAS PubMed PubMed Central Google Scholar
Seiler A. Fagundes CP, Christian LM. The impact of everyday stressors on the immune system and health. In: Choukèr A, editor. Stress challenges and immunity in space. Cham; Springer: 2020. https://doi.org/10.1007/978-3-030-16996-1_6.
Tabra SA, Elghany SEA, Amer RA, Fouda MH, Abu-Zaid MH. Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Clin Rheumatol. 2022;41:3391–9.
Article PubMed PubMed Central Google Scholar
Tong N, Zhang Y, Yang A, Dai X, Hao S. The potency of common proinflammatory cytokines measurement for revealing the risk and severity of anxiety and depression in psoriasis patients. J Clin Lab Anal. 2022;36:e24643.
Comments (0)